All adverse outcomes were of mild or moderate severity, and no significant trends were observed on the basis of LVEF status. The most common adverse events were hypotension (33%-36.4%), arrhythmia ...

Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test maker Exact Sciences Corp , Bloomberg ...

Gastrointestinal procedures continue to dominate the ASC landscape in 2025, driven by increased screening demand, younger-onset colorectal cancer and ongoing migration of cases out of hospitals. All ...

Hurricane Melissa close to breaking pressure record ahead of Jamaica landfall U.S. Strikes Draw Mexico Into Trump’s Campaign Against Drug Boats Dog and owner were killed at Tacoma homeless camp.

As screening guidelines evolve and GI care increasingly shifts to outpatient settings, ASCs are seeing significant growth in colonoscopy volume. Here are ten developments shaping that trend: ...

Scientists have created swallowable microsphere “pills” packed with engineered bacteria that can detect signs of gut disease, ...

Move over, colonoscopies—researchers report in ACS Sensors that they've developed a sensor made of tiny microspheres packed ...

Tens of millions of middle-aged and older Americans haven't gotten their recommended checks for early signs of potential ...

Chinese researchers have developed a new sensor made of tiny microspheres packed with blood-sensing bacteria that detect ...

Madison, Wisconsin-based Exact Sciences develops cancer screening and diagnostic tests. Its portfolio includes established brands like Cologuard and Oncotype Dx, alongside the Cancerguard test for ...

This week was my five-year colonoscopy. The fifth in my life. Colonoscopies are the best way to prevent colon cancer.